Fitzsimons Innovation Community is an integrated urban campus where health and life sciences companies of all sizes work on their next big things. Our customized workspace, collaborative campus, and proximity to one of the top health systems and medical schools in the country make our community the perfect place to put down roots and get to work.
MOVE-IN READY LAB SPACE
GROWTH OPPORTUNITIES
It’s not just additional space—it’s fifty sprawling acres of additional space. And it’s primed for ultra-custom, made-to-order facility development.
Fitzsimons Innovation Community and University of Colorado Anschutz Medical Campus working together.
Relationships that help you thrive.
FEATURED:
One of the most exciting times of year for us here at Fitzsimons Innovation Community is when we launch our Annual Innovation Report, and this year is no different. For the fourth year in a row, we are proud to share this report featuring updates, insight, and data about all the things that make our Community special.
Fitzsimons Innovation Community is where innovators come to turn ideas into business.
A regular feature of a Fitzsimons Innovation Community visionary.
Our year in innovation.
Find out what’s happening on campus and across the industry.
An urban mountain lifestyle for work and play.
Everything you need.
Right here.
Read Fitzsimons Innovation Community news, industry highlights, editorials, and innovation updates happening weekly on our campus.
Onconaut Therapeutics, a privately-held therapeutics company and prior Innosphere client company, has received $2.5M in funding through a Fast-Track Small Business Technology Transfer (STTR) grant from the National Institute of Health, National Cancer Institute (NCI) for Onconaut to develop small molecule drug inhibitor targeting Chromodomain Helicase DNA binding protein (CHD1L), a novel oncogenic target for metastatic colorectal cancer and other cancers. The grant will allow Onconaut to rapidly develop a lead compound suitable for preclinical IND studies as a single agent and in combination with FOLFIRI.
Never Dream Alone, the latest phase of the CU Anschutz advertising campaign, filmed in collaboration with the Colorado Symphony at Boettcher Concert Hall. The music mirrors the process of discovery at CU Anschutz – a lone idea blossoming into new cures and treatments through innovation and collaboration. “This campaign is about our people, their ideas and the power of collaboration,” said Chancellor Don Elliman. “It is by thinking and dreaming big together that we drive advancements in health and medicine. We’re proud to have worked alongside another crown jewel of our state in the Colorado Symphony to create this one-of-a-kind piece.”
This month, we're excited to welcome Elyse Blazevich as our guest blogger. As President & CEO of Colorado BioScience Association among many other roles, Elyse is at the forefront of Colorado's ambitious journey to become a Top Five life sciences destination. Her unique vantage point gives her unparalleled insight into what makes our state's health innovation ecosystem so special. We're thrilled to share her bold vision for Colorado's future and how Fitzsimons Innovation Community plays a pivotal role in that story.
National Geographic spotlighted groundbreaking research led by CU Anschutz experts, uncovering how COVID-19 and the flu may awaken dormant cancer cells. This discovery raises important questions for survivor care and demonstrates how Colorado researchers are advancing knowledge that impacts lives worldwide.
Fitzsimons Innovation Community Chief Operating Officer Kenneth Ho on the set of AuroraNow discussing the newly approved Master Plan, and how Fitzsimons plans to soften the edges of the campus through internship programs with local schools, community art installations, and other initiatives.
Researchers from University of Colorado Anschutz Medical Campus and University of Colorado Boulder have developed a gecko-inspired material that clings to bladder cancer tumors and slowly releases chemotherapy, introducing a promising new approach that could reduce the need for repeat treatments.
Denver’s 5280 Magazine has released its list of 2025 Top Doctors, and an incredible 610 University of Colorado School of Medicine faculty members earned the honor. University of Colorado Anschutz Medical Campus physicians continue to be recognized among the best across 75 specialties, congratulations to all who were honored this year!
Aurora City Council has approved a major residential expansion within the Fitzsimons Innovation Community, unlocking the potential for up to 7266 new housing units across the 184-acre campus. The development will support the area's growing life sciences hub, which is anchored by the CU Anschutz Medical Campus, and includes plans for mixed-use zones, residential-only areas, and improved infrastructure. With a minimum height of 4 stories for new buildings, the project aims to create a vibrant, walkable neighborhood that integrates seamlessly with the district’s cutting-edge research and medical facilities. Construction is expected to begin following resolution of final technical reviews.
Researchers at the University of Colorado Anschutz Medical Campus, Montefiore Einstein Comprehensive Cancer Center (MECCC) and Utrecht University have found the first direct evidence that common respiratory infections, including COVID-19 and influenza, can awaken dormant breast cancer cells that have spread to the lungs, setting the stage for new metastatic tumors. The findings were published in Nature.
Pharmaceutical Executive recently spoke with RheumaGen CEO Richard Freed about his career and the work the biotech is doing to find cures for autoimmune diseases.
Fitzsimons Innovation Community
